CN103755641A - 一种替米沙坦中间体的合成方法 - Google Patents
一种替米沙坦中间体的合成方法 Download PDFInfo
- Publication number
- CN103755641A CN103755641A CN201310691264.1A CN201310691264A CN103755641A CN 103755641 A CN103755641 A CN 103755641A CN 201310691264 A CN201310691264 A CN 201310691264A CN 103755641 A CN103755641 A CN 103755641A
- Authority
- CN
- China
- Prior art keywords
- reaction
- acid
- compound
- synthetic method
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010189 synthetic method Methods 0.000 title claims abstract description 17
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 239000005537 C09CA07 - Telmisartan Substances 0.000 title claims abstract description 8
- 229960005187 telmisartan Drugs 0.000 title claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- XWAJTVCEILFDGU-UHFFFAOYSA-N 7-methyl-2-propyl-3h-benzimidazole-5-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2NC(CCC)=NC2=C1C XWAJTVCEILFDGU-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940125773 compound 10 Drugs 0.000 claims abstract description 5
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims abstract description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 229940125797 compound 12 Drugs 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims description 7
- 229940125782 compound 2 Drugs 0.000 claims description 5
- 238000007034 nitrosation reaction Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000006722 reduction reaction Methods 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 3
- 238000007363 ring formation reaction Methods 0.000 claims description 3
- 229940095064 tartrate Drugs 0.000 claims description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 239000012445 acidic reagent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 230000009935 nitrosation Effects 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims 2
- 230000007547 defect Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- XRSQZFJLEPBPOZ-UHFFFAOYSA-N 4-amino-2-methylbenzoic acid Chemical compound CC1=CC(N)=CC=C1C(O)=O XRSQZFJLEPBPOZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000001816 cooling Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 239000005457 ice water Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000010792 warming Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229940083963 Peptide antagonist Drugs 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310691264.1A CN103755641B (zh) | 2013-12-07 | 2013-12-07 | 一种替米沙坦中间体的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310691264.1A CN103755641B (zh) | 2013-12-07 | 2013-12-07 | 一种替米沙坦中间体的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103755641A true CN103755641A (zh) | 2014-04-30 |
CN103755641B CN103755641B (zh) | 2017-12-22 |
Family
ID=50523002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310691264.1A Active CN103755641B (zh) | 2013-12-07 | 2013-12-07 | 一种替米沙坦中间体的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103755641B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3691166A (en) * | 1969-12-19 | 1972-09-12 | Merck & Co Inc | Substituted quinoxalines |
CN1454891A (zh) * | 2003-05-26 | 2003-11-12 | 北京理工大学 | 苯并咪唑及其衍生物合成新方法 |
CN101024631A (zh) * | 2007-03-08 | 2007-08-29 | 杭州盛美医药科技开发有限公司 | 替米沙坦的中间体及其制备与应用 |
CN102060778A (zh) * | 2010-12-24 | 2011-05-18 | 江苏江神药物化学有限公司 | 一种4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的合成方法 |
-
2013
- 2013-12-07 CN CN201310691264.1A patent/CN103755641B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3691166A (en) * | 1969-12-19 | 1972-09-12 | Merck & Co Inc | Substituted quinoxalines |
CN1454891A (zh) * | 2003-05-26 | 2003-11-12 | 北京理工大学 | 苯并咪唑及其衍生物合成新方法 |
CN101024631A (zh) * | 2007-03-08 | 2007-08-29 | 杭州盛美医药科技开发有限公司 | 替米沙坦的中间体及其制备与应用 |
CN102060778A (zh) * | 2010-12-24 | 2011-05-18 | 江苏江神药物化学有限公司 | 一种4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的合成方法 |
Non-Patent Citations (2)
Title |
---|
LING-CHUN YANG,ET AL.: "Facile Synthesis of Novel Nonpeptide Angiotensin II Receptor Antagonists", 《J. HETEROCYCLIC CHEM.》 * |
UWE J. RIES, ET AL.: "6-Substituted Benzimidazoles as New Nonpeptide Angiotensin I1 Receptor Antagonists: Synthesis, Biological Activity, and Structure-Activity Relationships", 《J. MED. CHEM.》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103755641B (zh) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103058993B (zh) | 一种氯虫苯甲酰胺的制备方法 | |
CN102558056B (zh) | 塞来昔布及其制备方法 | |
CN109608414B (zh) | 检测过氧亚硝酸根的荧光探针及其制备方法和应用 | |
CN102321028A (zh) | 一种合成2-甲基-5-硝基咪唑-1-乙醇的方法 | |
CN103102351B (zh) | 一种制备高纯度叶酸的精制方法 | |
CN106800512A (zh) | 一种3,5‑二硝基邻甲基苯甲酸的制备方法及制备装置 | |
CN111217764A (zh) | 一种制备6-硝基-1,2,4-酸氧体的方法 | |
CN106699664A (zh) | 一种4‑氨基安替比林产品的合成工艺 | |
CN106854163A (zh) | 一种盐酸多西环素中间体氢化物的制备工艺 | |
CN101348465A (zh) | 盐酸咪唑苯脲的制备方法 | |
CN103755641A (zh) | 一种替米沙坦中间体的合成方法 | |
CN101541798B (zh) | 米氮平的制造方法 | |
CN108976233A (zh) | 巴瑞替尼的杂质及其制备、检测方法 | |
CN107335383A (zh) | 含偶氮苯联接链的易溶型阳离子双子表面活性剂及其制备方法和应用 | |
CN103804310A (zh) | 一种制备高纯度7-氯-5-苯基-苯并二氮杂卓-2-酮的方法 | |
CN105884644A (zh) | 一种中性内肽酶抑制剂盐优势形态及其制备方法 | |
CN111848517A (zh) | 一种依达拉奉的制备方法 | |
CN102329317B (zh) | 一种可可碱的合成方法 | |
CN110511182B (zh) | 一种连续流反应合成7-硝基-1,2,3,4-四氢喹啉的方法 | |
CN104151170A (zh) | 4-硝基苯乙胺盐酸盐及其制备方法 | |
CN105820054A (zh) | 一种3-甲基-2-硝基苯甲酸甲酯的制备方法 | |
CN102702203A (zh) | 一种美罗培南的精制方法 | |
CN103333116B (zh) | 1-甲酰基-2-取代苯并咪唑及其制备方法和应用 | |
CN103739502B (zh) | 一种氨溴索碱的分离精制工艺 | |
CN106748912B (zh) | 一种薁磺酸钠一水合物的合成工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: WEIHAI DISU PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WEIHAI DIZHIYA PHARMACHEM. DEVELOPMENT CO., LTD. Effective date: 20150908 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150908 Address after: Economic and Technological Development Zone of Shandong Province, Weihai City, Gushan Town, 264209 South Road, No. 18, No. 19 North Road, No. 3 East Road, the west five Applicant after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Applicant after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 Shandong Province, Weihai District No. 18 by Gu Shan Zhen South Road, No. 19 North Road, No. 3 East Road, five West Bank Applicant before: WEIHAI DIZHIYA PHARMACHEM DEV Co.,Ltd. Applicant before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Applicant before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191023 Address after: 264205 Guangzhou East Road South and an East Road East, Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Co-patentee after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Co-patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: Economic and Technological Development Zone of Shandong Province, Weihai City, Gushan Town, 264209 No. 18 South Road, No. 19 North Road, No. 3 East Road, the west five Co-patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210617 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 268, Tianrun Road, Wendeng Economic and Technological Development Zone, Weihai City, Shandong Province, 264200 Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |